IBDEI0CY ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17353,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,17354,0)
 ;;=V58.61^^88^937^126
 ;;^UTILITY(U,$J,358.3,17354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17354,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,17354,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,17354,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,17355,0)
 ;;=282.49^^88^937^117
 ;;^UTILITY(U,$J,358.3,17355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17355,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,17355,1,5,0)
 ;;=5^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,17355,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,17356,0)
 ;;=289.89^^88^937^15
 ;;^UTILITY(U,$J,358.3,17356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17356,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,17356,1,5,0)
 ;;=5^Blood Diseases NEC
 ;;^UTILITY(U,$J,358.3,17356,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,17357,0)
 ;;=238.79^^88^937^88
 ;;^UTILITY(U,$J,358.3,17357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17357,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,17357,1,5,0)
 ;;=5^Lymph/Hematopoietic Tissue NEC
 ;;^UTILITY(U,$J,358.3,17357,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,17358,0)
 ;;=287.30^^88^937^110
 ;;^UTILITY(U,$J,358.3,17358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17358,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,17358,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,17358,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,17359,0)
 ;;=288.09^^88^937^8
 ;;^UTILITY(U,$J,358.3,17359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17359,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,17359,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,17359,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,17360,0)
 ;;=V10.21^^88^937^61
 ;;^UTILITY(U,$J,358.3,17360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17360,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,17360,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,17360,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,17361,0)
 ;;=284.2^^88^937^106
 ;;^UTILITY(U,$J,358.3,17361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17361,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,17361,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,17361,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,17362,0)
 ;;=202.40^^88^937^76
 ;;^UTILITY(U,$J,358.3,17362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17362,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,17362,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,17362,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,17363,0)
 ;;=287.49^^88^937^118
 ;;^UTILITY(U,$J,358.3,17363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17363,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,17363,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,17363,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,17364,0)
 ;;=180.9^^88^937^29
 ;;^UTILITY(U,$J,358.3,17364,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17364,1,4,0)
 ;;=4^180.9
 ;;^UTILITY(U,$J,358.3,17364,1,5,0)
 ;;=5^Ca Cervix
 ;;^UTILITY(U,$J,358.3,17364,2)
 ;;=^267214
 ;;^UTILITY(U,$J,358.3,17365,0)
 ;;=203.02^^88^937^104
 ;;^UTILITY(U,$J,358.3,17365,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17365,1,4,0)
 ;;=4^203.02
 ;;^UTILITY(U,$J,358.3,17365,1,5,0)
 ;;=5^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,17365,2)
 ;;=^336462
 ;;^UTILITY(U,$J,358.3,17366,0)
 ;;=204.02^^88^937^2
 ;;^UTILITY(U,$J,358.3,17366,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17366,1,4,0)
 ;;=4^204.02
 ;;^UTILITY(U,$J,358.3,17366,1,5,0)
 ;;=5^ALL,In Relapse
 ;;^UTILITY(U,$J,358.3,17366,2)
 ;;=^336465
 ;;^UTILITY(U,$J,358.3,17367,0)
 ;;=204.12^^88^937^17
 ;;^UTILITY(U,$J,358.3,17367,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17367,1,4,0)
 ;;=4^204.12
 ;;^UTILITY(U,$J,358.3,17367,1,5,0)
 ;;=5^CLL,In Relapse
 ;;^UTILITY(U,$J,358.3,17367,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,17368,0)
 ;;=204.20^^88^937^114
 ;;^UTILITY(U,$J,358.3,17368,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17368,1,4,0)
 ;;=4^204.20
 ;;^UTILITY(U,$J,358.3,17368,1,5,0)
 ;;=5^Subacute LL w/o Remission
 ;;^UTILITY(U,$J,358.3,17368,2)
 ;;=^336852
 ;;^UTILITY(U,$J,358.3,17369,0)
 ;;=204.21^^88^937^116
 ;;^UTILITY(U,$J,358.3,17369,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17369,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,17369,1,5,0)
 ;;=5^Subacute LL,In Remission
 ;;^UTILITY(U,$J,358.3,17369,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,17370,0)
 ;;=204.22^^88^937^115
 ;;^UTILITY(U,$J,358.3,17370,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17370,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,17370,1,5,0)
 ;;=5^Subacute LL,In Relapse
 ;;^UTILITY(U,$J,358.3,17370,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,17371,0)
 ;;=205.02^^88^937^5
 ;;^UTILITY(U,$J,358.3,17371,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17371,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,17371,1,5,0)
 ;;=5^AML,In Relapse
 ;;^UTILITY(U,$J,358.3,17371,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,17372,0)
 ;;=205.12^^88^937^20
 ;;^UTILITY(U,$J,358.3,17372,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17372,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,17372,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,17372,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,17373,0)
 ;;=284.81^^88^937^14
 ;;^UTILITY(U,$J,358.3,17373,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17373,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,17373,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,17373,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,17374,0)
 ;;=284.89^^88^937^13
 ;;^UTILITY(U,$J,358.3,17374,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17374,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,17374,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,17374,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,17375,0)
 ;;=289.84^^88^937^119
 ;;^UTILITY(U,$J,358.3,17375,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17375,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,17375,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,17375,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,17376,0)
 ;;=V10.91^^88^937^67
 ;;^UTILITY(U,$J,358.3,17376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17376,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,17376,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,17376,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,17377,0)
 ;;=V10.91^^88^937^66
 ;;^UTILITY(U,$J,358.3,17377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17377,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,17377,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,17377,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,17378,0)
 ;;=465.9^^88^938^70
 ;;^UTILITY(U,$J,358.3,17378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17378,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,17378,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,17378,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,17379,0)
 ;;=462.^^88^938^61
 ;;^UTILITY(U,$J,358.3,17379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17379,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,17379,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,17379,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,17380,0)
 ;;=466.0^^88^938^3
 ;;^UTILITY(U,$J,358.3,17380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17380,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,17380,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,17380,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,17381,0)
 ;;=112.1^^88^938^79
 ;;^UTILITY(U,$J,358.3,17381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17381,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,17381,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,17381,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,17382,0)
 ;;=616.0^^88^938^13
 ;;^UTILITY(U,$J,358.3,17382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17382,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,17382,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,17382,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,17383,0)
 ;;=599.0^^88^938^71
 ;;^UTILITY(U,$J,358.3,17383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17383,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,17383,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,17383,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,17384,0)
 ;;=460.^^88^938^45
 ;;^UTILITY(U,$J,358.3,17384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17384,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,17384,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,17384,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,17385,0)
 ;;=372.30^^88^938^14
 ;;^UTILITY(U,$J,358.3,17385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17385,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,17385,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,17385,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,17386,0)
 ;;=595.9^^88^938^15
 ;;^UTILITY(U,$J,358.3,17386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17386,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,17386,1,5,0)
 ;;=5^Cystitis
 ;;^UTILITY(U,$J,358.3,17386,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,17387,0)
 ;;=110.1^^88^938^16
 ;;^UTILITY(U,$J,358.3,17387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17387,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,17387,1,5,0)
 ;;=5^Dermatophytosis Nail
 ;;^UTILITY(U,$J,358.3,17387,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,17388,0)
 ;;=562.11^^88^938^17
 ;;^UTILITY(U,$J,358.3,17388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17388,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,17388,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,17388,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,17389,0)
 ;;=424.90^^88^938^18
 ;;^UTILITY(U,$J,358.3,17389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17389,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,17389,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,17389,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,17390,0)
 ;;=604.90^^88^938^19
 ;;^UTILITY(U,$J,358.3,17390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17390,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,17390,1,5,0)
 ;;=5^Epididymitis
 ;;^UTILITY(U,$J,358.3,17390,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,17391,0)
 ;;=558.9^^88^938^22
 ;;^UTILITY(U,$J,358.3,17391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17391,1,4,0)
 ;;=4^558.9
